Notably, the regulatory networks of glutamate receptor signaling (Fig. 1 F and Fig. S1 E), and here in particular the MS-associated GRIK4 and GRM8 (Fig. 1 G and Fig. S1 F), were strongly enriched in EN-PYRs of MS patients. This evidence concerns the gene GRIK4 and myeloid sarcoma.